PAPER Ramezani M, Komaki A, Hashemi-Firouzi N, Mortezaee K, Faraji N, Golipoor Z
SEARCH RESULTS
1339 RESULTS
PAPER Sandrino B, Jochelavicius K, Volpati D, Barbosa SC, Nobre TM, Oliveira ON Jr
The prion fragment PrP106-127 adopts a secondary structure typical of aggregated fibrils in langmuir monolayers of brain lipid extract.
Chem Phys Lipids. 2020 Aug;230:104930. Epub 2020 May 26 PubMed: 32470442PAPER Masters CL
Major risk factors for Alzheimer's disease: age and genetics.
Lancet Neurol. 2020 Jun;19(6):475-476. Epub 2020 May 26 PubMed: 32470411PAPER Meng L, Li XY, Shen L, Ji HF
Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities.
Trends Mol Med. 2020 Jun;26(6):597-614. Epub 2020 Mar 23 PubMed: 32470386PAPER Maes T, Mascaró C, Rotllant D, Lufino MM, Estiarte A, Guibourt N, Cavalcanti F, Griñan-Ferré C, Pallàs M, Nadal R, Armario A, Ferrer I, Ortega A, Valls N, Fyfe M, Martinell M, Castro Palomino JC, Buesa Arjol C
Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations.
PLoS One. 2020;15(5):e0233468. Epub 2020 May 29 PubMed: 32469975PAPER Sos KE, Mayer MI, Takács VT, Major A, Bardóczi Z, Beres BM, Szeles T, Saito T, Saido TC, Mody I, Freund TF, Nyiri G
Amyloid β induces interneuron-specific changes in the hippocampus of APPNL-F mice.
PLoS One. 2020;15(5):e0233700. Epub 2020 May 29 PubMed: 32469963PAPER Khorvash M, Blinov N, Ladner-Keay C, Lu J, Silverman JM, Gibbs E, Wang YT, Kovalenko A, Wishart D, Cashman NR
Molecular interactions between monoclonal oligomer-specific antibody 5E3 and its amyloid beta cognates.
PLoS One. 2020;15(5):e0232266. Epub 2020 May 29 PubMed: 32469918PAPER Tsai CW, Tsai CF, Lin KH, Chen WJ, Lin MS, Hsieh CC, Lin CC
An investigation of the correlation between the S-glutathionylated GAPDH levels in blood and Alzheimer's disease progression.
PLoS One. 2020;15(5):e0233289. Epub 2020 May 29 PubMed: 32469899PAPER Zhang Z, Wei F, Shen XN, Ma YH, Chen KL, Dong Q, Tan L, Yu JT, Alzheimer's Disease Neuroimaging Initiative
Associations of Subsyndromal Symptomatic Depression with Cognitive Decline and Brain Atrophy in Elderly Individuals without Dementia: A Longitudinal Study.
J Affect Disord. 2020 Sep 1;274:262-268. Epub 2020 May 23 PubMed: 32469814PAPER Popugaeva E, Chernyuk D, Bezprozvanny I
Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease.
Curr Alzheimer Res. 2020;17(4):344-354. PubMed: 32469698PAPER Cox SJ, Lam B, Prasad A, Marietta HA, Stander NV, Joel JG, Sahoo BR, Guo F, Stoddard AK, Ivanova MI, Ramamoorthy A
High-Throughput Screening at the Membrane Interface Reveals Inhibitors of Amyloid-β.
Biochemistry. 2020 Jun 23;59(24):2249-2258. Epub 2020 Jun 5 PubMed: 32469202PAPER Geerts H, van der Graaf PH
Salvaging CNS Clinical Trials Halted Due to COVID-19.
CPT Pharmacometrics Syst Pharmacol. 2020 Jul;9(7):367-370. Epub 2020 Jun 28 PubMed: 32468710PAPER Turner RS, Hebron ML, Lawler A, Mundel EE, Yusuf N, Starr JN, Anjum M, Pagan F, Torres-Yaghi Y, Shi W, Mulki S, Ferrante D, Matar S, Liu X, Esposito G, Berkowitz F, Jiang X, Ahn J, Moussa C
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease.
Ann Neurol. 2020 Jul;88(1):183-194. Epub 2020 May 28 PubMed: 32468646PAPER Vrahatis AG, Kotsireas IS, Vlamos P
Detecting Common Pathways and Key Molecules of Neurodegenerative Diseases from the Topology of Molecular Networks.
Adv Exp Med Biol. 2020;1194:409-421. PubMed: 32468556PAPER Vrahatis AG, Kotsireas IS, Vlamos P
A Systems Biology Approach for the Identification of Active Molecular Pathways During the Progression of Alzheimer's Disease.
Adv Exp Med Biol. 2020;1194:303-314. PubMed: 32468546Current Filters
- Date Range : May 2020 to Jun 2020 x